Clinical Practice Recommendations for the Use of Next-Generation Sequencing in Patients with Solid Cancer: A Joint Report from KSMO and KSP / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment
; : 721-742, 2024.
Article
in En
| WPRIM
| ID: wpr-1042373
Responsible library:
WPRO
ABSTRACT
In recent years, next-generation sequencing (NGS)–based genetic testing has become crucial in cancer care. While its primary objective is to identify actionable genetic alterations to guide treatment decisions, its scope has broadened to encompass aiding in pathological diagnosis and exploring resistance mechanisms. With the ongoing expansion in NGS application and reliance, a compelling necessity arises for expert consensus on its application in solid cancers. To address this demand, the forthcoming recommendations not only provide pragmatic guidance for the clinical use of NGS but also systematically classify actionable genes based on specific cancer types. Additionally, these recommendations will incorporate expert perspectives on crucial biomarkers, ensuring informed decisions regarding circulating tumor DNA panel testing.
Full text:
1
Database:
WPRIM
Language:
En
Journal:
Cancer Research and Treatment
Year:
2024
Document type:
Article